The national institute for communicable diseases (NICD)

Is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent.

BLOG POSTS

FOR HEALTHCARE WORKERS-WHAT'S NEW

THE USE OF IVERMECTIN FOR THE TREATMENT OF PREVENTION OF COVID-19Jan 2021
Read More
The use of ivermectin for the treatment of prevention of COVID-19 has generated significant global interest. The use of this repurposed medicine is being heavily promoted via social media. However, given the limited evidence of efficacy and safety, as well as appropriate dosing of ivermectin, its place in therapy and prophylaxis remains uncertain at this point.
ANTIGEN TESTING GUIDELINEDec 2020
Read More
Whilst PCR testing remains the gold standard for diagnosing SARS-CoV-2 infection, antigen testing provides an important alternative. This document explores the impact of antigen testing for various use cases and guides the implementation of these tests across different settings.
GUIDELINES FOR SYMPTOMS MONITORING AND MANAGEMENT OF ESSENTIAL WORKERS FOR COVID-19 RELATED INFECTIONDEC 2020
Read More
The aim of this guideline is to enable early and timeous identification and diagnosis of workers at risk of COVID-19 infection. Another aim is the early referral for appropriate treatment, care and timeous return to work of affected workers.
GUIDELINES FOR PERSONAL PROTECTIVE EQUIPMENT SPECIFICATIONS
GUIDELINES FOR PERSONAL PROTECTIVE EQUIPMENT SPECIFICATIONSUpdated OCT 2020
Read More
This guideline provides guidance for developing tender specifications and procuring the required standard and quality of personal protective equipment (PPE), body bags, disinfectants, alcohol-based hand rub (ABHR) and thermometers for use during the COVID-19 pandemic.
POLICY FOR THE REGULATION OF QUALITY RESPIRATORY PROTECTIVE EQUIPMENT SUPPLY IN HEALTHCAREUpdated Oct 2020
Read More
The intention of this policy is to ensure that all health workers in South Africa are afforded access to quality respiratory protective equipment, and in particular half face particulate respirators. This translates into best protection against COVID-19 , TB and any other respiratory infectious disease during and post the COVID-19 pandemic.
COVID-19 QUICK REFERENCE FOR HEALTHCARE WORKERSVersion 15 (uploaded 1 Sept 2020)
Read More
A quick reference for healthcare workers that summarises the presentation and management of suspected cases, mandatory information to be provided on lab request forms, specimens required for SARS-CoV-2 PCR testing and much more.
Previous
Next

LEARN MORE ABOUT COVID-19

LATEST SCIENTIFIC PUBLICATIONS

The utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in RSA to guide mitigation strategies
The utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in RSA to guide mitigation strategies
Read More
The COVID-19 pandemic has been marked by extreme heterogeneity in both geography and population across the world. Consequently, leveraging local data aligned to the unique South African (SA) context is critical.
COVID-19–We urgently need to start developing an exit strategy
COVID-19–We urgently need to start developing an exit strategy
Read More
With the SARS-CoV-2 pandemic passing one million ill people (1 521 252 confirmed cases and 92 798 reported deaths (WHO Sit Rep 10 April), most countries are occupied with controlling the outbreak. The economic consequences are enormous. The World Trade Organization (WTO) estimates that “commerce could shrink up to 32% and warns against 30s-style protectionism” [WTO, 2020]. With no vaccine and no proven effective treatment, the tools available are limited to physical distancing, which includes quarantine and travel restrictions.
Whole-Genome Sequence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) obtained from a South African Coronavirus Disease 2019 (COVID-19) Patient
Whole-Genome Sequence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) obtained from a South African Coronavirus Disease 2019 (COVID-19) Patient
Read More
A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from a South African patient with coronavirus disease 2019 (COVID-19), who had returned to South Africa after traveling to Italy.
Previous
Next
Close Menu